Gonçalo and colleagues [16] patch-tested 66 patients (aged 12 to 83 years) with a history of a maculopapular rash ... of 3), clindamycin (1 of 3), and espiramycin (1 of 2), and no reactions ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adults and adolescents with ...

An asthma medication called omalizumab can stop your body from having an allergic response to pollen and even food.

Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification ...

Residents say the toxic air also causes skin rashes and eye irritation, damages crops, and restricts routine tasks like drying laundry outdoors. "Everything is covered with dust or soot," said ...

The FDA has approved Dupixent for the treatment of patients aged 12 years and older with CSU who remain symptomatic despite H1 antihistamine treatment.

Residents say the toxic air also causes skin rashes and eye irritation ... cardiac arrest 8:23 PM UTC · Updated ago Worldcategory Reactions to the death of Pope Francis 8:15 PM UTC · Updated ...

Two-year-old Sumaiya Ansari, a resident of India's Byrnihat town which is ranked the world's most polluted metropolitan area by Swiss Group IQAir, was battling breathing problems for several days ...

Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives ...

Full-strength dosing should last for 3–4 weeks or until a response is noted, and a reduction to half strength is recommended until the rash is resolved ... that daily clindamycin gel resolved ...